Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin plus Rifaximin for Decompensated Cirrhosis (LIVERHOPE_EFFICACY)
NCT03780673Phase 3Completed
- Start
- Jan 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of simvastatin, rifaximin in decompensated cirrhosis. Started Jan 2019; status: completed.
02
Drugs
simvastatinrifaximin
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT03780673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03780673.